BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 20674564)

  • 1. In vitro binding characteristics of [3H]AZ11637326, a novel alpha7-selective neuronal nicotinic receptor agonist radioligand.
    Gordon JC; Phillips E; Gurley DA; Heys JR; Lazor LA; Barthlow HG; Mallamaci MA; Keith RA
    Eur J Pharmacol; 2010 Oct; 645(1-3):63-9. PubMed ID: 20674564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.
    Anderson DJ; Bunnelle W; Surber B; Du J; Surowy C; Tribollet E; Marguerat A; Bertrand D; Gopalakrishnan M
    J Pharmacol Exp Ther; 2008 Jan; 324(1):179-87. PubMed ID: 17959745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical validation of a novel alpha-7 nicotinic receptor radiotracer, [(3)H]AZ11637326: target localization, biodistribution and ligand occupancy in the rat brain.
    Maier DL; Hill G; Ding M; Tuke D; Einstein E; Gurley D; Gordon JC; Bock MJ; Smith JS; Bialecki R; Eisman M; Elmore CS; Werkheiser JL
    Neuropharmacology; 2011; 61(1-2):161-71. PubMed ID: 21497612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.
    Ravert HT; Dorff P; Foss CA; Mease RC; Fan H; Holmquist CR; Phillips E; McCarthy DJ; Heys JR; Holt DP; Wang Y; Endres CJ; Dannals RF; Pomper MG
    Nucl Med Biol; 2013 Aug; 40(6):731-9. PubMed ID: 23680470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of [(125)I]CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranes.
    Wu J; Toyohara J; Tanibuchi Y; Fujita Y; Zhang J; Chen H; Matsuo M; Wang RF; Hashimoto K
    Brain Res; 2010 Nov; 1360():130-7. PubMed ID: 20816767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
    Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor.
    Mullen G; Napier J; Balestra M; DeCory T; Hale G; Macor J; Mack R; Loch J; Wu E; Kover A; Verhoest P; Sampognaro A; Phillips E; Zhu Y; Murray R; Griffith R; Blosser J; Gurley D; Machulskis A; Zongrone J; Rosen A; Gordon J
    J Med Chem; 2000 Nov; 43(22):4045-50. PubMed ID: 11063601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosynthesis and in vitro validation of (3)H-NS14492 as a novel high affinity alpha7 nicotinic receptor radioligand.
    Magnussen JH; Ettrup A; Donat CK; Peters D; Pedersen MH; Knudsen GM; Mikkelsen JD
    Eur J Pharmacol; 2015 Sep; 762():35-41. PubMed ID: 25941084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands.
    Molinari EJ; Delbono O; Messi ML; Renganathan M; Arneric SP; Sullivan JP; Gopalakrishnan M
    Eur J Pharmacol; 1998 Apr; 347(1):131-9. PubMed ID: 9650859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atomic force microscopy to characterize binding properties of α7-containing nicotinic acetylcholine receptors on neurokinin-1 receptor-expressing medullary respiratory neurons.
    Clark CG; Sun Z; Meininger GA; Potts JT
    Exp Physiol; 2013 Feb; 98(2):415-24. PubMed ID: 22962286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.
    Biton B; Bergis OE; Galli F; Nedelec A; Lochead AW; Jegham S; Godet D; Lanneau C; Santamaria R; Chesney F; Léonardon J; Granger P; Debono MW; Bohme GA; Sgard F; Besnard F; Graham D; Coste A; Oblin A; Curet O; Vigé X; Voltz C; Rouquier L; Souilhac J; Santucci V; Gueudet C; Françon D; Steinberg R; Griebel G; Oury-Donat F; George P; Avenet P; Scatton B
    Neuropsychopharmacology; 2007 Jan; 32(1):1-16. PubMed ID: 17019409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of [(3)H]CHIBA-1001 binding to alpha7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human.
    Tanibuchi Y; Wu J; Toyohara J; Fujita Y; Iyo M; Hashimoto K
    Brain Res; 2010 Aug; 1348():200-8. PubMed ID: 20537987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonist.
    Feuerbach D; Nozulak J; Lingenhoehl K; McAllister K; Hoyer D
    Neurosci Lett; 2007 Apr; 416(1):61-5. PubMed ID: 17314009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells.
    Ridley DL; Rogers A; Wonnacott S
    Br J Pharmacol; 2001 Aug; 133(8):1286-95. PubMed ID: 11498514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
    Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
    Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
    Jonnala RR; Buccafusco JJ
    J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors.
    Innocent N; Livingstone PD; Hone A; Kimura A; Young T; Whiteaker P; McIntosh JM; Wonnacott S
    J Pharmacol Exp Ther; 2008 Nov; 327(2):529-37. PubMed ID: 18664588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.
    Sharples CG; Karig G; Simpson GL; Spencer JA; Wright E; Millar NS; Wonnacott S; Gallagher T
    J Med Chem; 2002 Jul; 45(15):3235-45. PubMed ID: 12109907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain.
    Whiteaker P; Davies AR; Marks MJ; Blagbrough IS; Potter BV; Wolstenholme AJ; Collins AC; Wonnacott S
    Eur J Neurosci; 1999 Aug; 11(8):2689-96. PubMed ID: 10457165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity between rat brain nicotinic alpha-bungarotoxin receptors and stably expressed alpha-bungarotoxin binding sites.
    Quik M; Choremis J; Komourian J; Lukas RJ; Puchacz E
    J Neurochem; 1996 Jul; 67(1):145-54. PubMed ID: 8666985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.